Acne is a prevalent skin condition in Singapore that occurs when hair follicles become clogged with oil, dead skin cells, and bacteria. While commonly associated with teenagers, acne can affect individuals of all ages. Learning what causes acne is essential to choosing the right treatments to prevent breakouts and achieve clearer skin.
Acne can be triggered by multiple factors, including:
Acne appears in different forms, which can range from mild to severe:
Understanding the specific type of acne you have is key to selecting the most effective treatments, whether it involves skincare products, medications, or medical treatments such as lasers or facials.
For individuals with moderate to severe acne that doesn't respond to topical treatments, oral medications may be recommended. These medications work internally to target the underlying causes of acne, such as bacteria, inflammation, and hormonal imbalances. Below are the common types of oral medications used for acne treatment in Singapore.
Oral antibiotics, such as Doxycycline are frequently prescribed to treat moderate to severe acne. They work by:
These medications are typically prescribed for a limited duration (around 3 to 8 months) to minimize the risk of antibiotic resistance. Oral antibiotics are often combined with topical treatments for better results.
Hormonal imbalances are a common cause of acne in women, particularly during menstrual cycles, pregnancy, or menopause. Spironolactone is a medication that can effectively treat hormonal acne in ladies by:
Spironolactone is typically used for adult women with persistent acne and may also benefit those with conditions like polycystic ovary syndrome (PCOS).
For stubborn or severe cystic acne, Isotretinoin (commonly known as Accutane) is considered one of the most effective treatments. It works by:
Isotretinoin is often prescribed for patients with severe nodules, cysts, or acne that has caused scarring. However, it requires close medical supervision due to potential side effects, such as dry skin, sensitivity, and rare systemic reactions.
Before starting oral medications for acne, it is crucial to consult a medical professional who can evaluate your condition and recommend the most appropriate treatment. Some medications, such as Isotretinoin, require regular follow-ups to monitor for side effects and ensure safe use.
By targeting the root causes of acne from within, oral medications can provide significant improvements, especially for individuals with persistent or severe acne in Singapore.
The Pro Yellow Laser is a treatment for active acne and post-acne red marks, offering a non-invasive solution with minimal downtime. Its 577nm wavelength effectively targets acne-causing bacteria, reduces inflammation, and diminishes red acne scars.
How the Pro Yellow Laser Works:
Treatment Experience:
Acne facials with extraction are highly effective treatments designed to combat acne by deeply cleansing the skin, removing impurities, and reducing inflammation. At Edwin Lim Medical Aesthetic Clinic, we offer advanced acne facial treatments, including the Aquapure Medi-Facial, to target acne at its root while improving overall skin health.
Key Benefits of Acne Facials with Extraction:
Why Choose Acne Facials with Extraction?
Topical skincare products are a vital part of acne management in Singapore, addressing issues like clogged pores, inflammation, and acne-causing bacteria. At Edwin Lim Medical Aesthetic Clinic, we focus on evidence-based ingredients to provide effective solutions for acne-prone skin.
1. Salicylic Acid
2. Glycolic Acid and Lactic Acid
3. Azelaic Acid
4. Tea Tree Oil and Witch Hazel Extract
5. Niacinamide (Vitamin B3)
6. Topical Antibiotics (e.g., Clindamycin, Neomycin)
7. Anti-Inflammatory and Antibacterial Ingredients
8. Soothing and Hydrating Agents (Aloe Vera, Chamomile, Ginseng)
Why These Ingredients Are Effective
The combination of exfoliating acids, antibacterial agents, and soothing ingredients works synergistically to tackle multiple causes of acne, including bacterial overgrowth, inflammation, and post-acne marks. Regular use of these ingredients can help clear acne while maintaining skin health and balance.
Effectively managing acne requires a holistic approach tailored to your unique skin concerns. From medical-grade topical skincare and oral medications to advanced treatments like the Pro Yellow Laser and acne facials with extraction, a combination of strategies can target the root causes of acne and promote long-term skin health.
At Edwin Lim Medical Aesthetic Clinic, we specialize in providing customized acne treatment plans in Singapore to address acne at every stage—whether it’s mild, moderate, or severe cystic acne. Our treatments are designed to reduce breakouts, fade post-acne marks, and prevent future flare-ups while improving your skin’s texture and clarity.
Take the first step toward achieving clearer skin with a consultation and discover how our evidence-based acne treatments in Singapore can restore your confidence and leave your skin looking healthier and more radiant.
In Singapore, doctor-prescribed weight loss injection pens have become an important option for individuals seeking medical support for weight management. These treatments include once-weekly and daily GLP-1 receptor agonist injections, which are internationally recognised and available under various brand names.
These prescription pens deliver medications such as semaglutide, tirzepatide, and liraglutide. By acting on appetite regulation and metabolic pathways, these treatments may support weight reduction in suitable patients under medical supervision.
Weekly injection pens containing semaglutide are available in both standard (0.25–1mg) and higher-dose (up to 2.4mg) versions. The dual agonist injection pen with tirzepatide is a more recent development, while the daily liraglutide injection pen is a well-established option for weight management.
This guide provides an overview of GLP-1 and dual agonist weight loss injection pens in Singapore, including their mechanisms of action, who may be eligible for treatment, and what to expect during the process.
GLP-1 and dual agonist weight loss injection pens are doctor-prescribed medications used in Singapore to assist with medical weight management in adults with overweight or obesity.
These injectable treatments are administered as either once-weekly or daily injections, depending on the medication, and act on hormonal pathways that regulate appetite, satiety, and metabolism.
Several active ingredients are used in these pens, including semaglutide, tirzepatide, and liraglutide. All require a medical consultation, prescription, and ongoing monitoring to ensure safety and suitability.
Prescription weight loss injection pens in Singapore are available as both weekly and daily options. The main types are:
Each option is chosen based on clinical assessment and individual needs. For dosing details and specific indications, see the section below.
These ingredients work by supporting appetite regulation, calorie reduction, and improved metabolic control.
Weight loss injection pens help reduce body weight by targeting hormones that influence hunger, fullness, and energy balance. These mechanisms make them effective as part of a comprehensive, medically supervised weight management plan.
GLP-1 receptor agonists such as semaglutide and liraglutide mimic the effects of the natural GLP-1 hormone, increasing satiety, reducing hunger, and slowing gastric emptying. This can result in decreased caloric intake and gradual, sustained weight loss.
Dual agonist injections with tirzepatide activate both GLP-1 and GIP pathways, providing an additional effect on appetite and glucose control, which may lead to greater weight reduction for some individuals.
The most appropriate dosing schedule is determined by a doctor during the initial assessment and follow-up consultations.
This section details each type of weight loss injection pen available in Singapore, including specific dosing, titration protocols, and unique considerations for each medication.
The once-weekly semaglutide pen is prescribed at standard doses ranging from 0.25mg to 1mg. It is indicated for both type 2 diabetes and weight management.
Treatment typically starts at the lowest dose, with gradual increases based on clinical response and tolerance. This pen offers a familiar and convenient weekly regimen for many patients.
A high-dose version of the once-weekly semaglutide pen is specifically indicated for weight management in adults with overweight or obesity.
Dosing begins at 0.25mg and is increased over several weeks up to a maximum of 2.4mg weekly, as guided by your doctor. This escalation protocol is designed to minimise side effects while achieving optimal results.
The tirzepatide injection pen is a next-generation, dual agonist therapy targeting both GLP-1 and GIP receptors for enhanced weight loss support.
It is available in multiple dosing strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg.
Treatment usually starts at the lowest available dose, with titration at regular intervals to achieve the desired therapeutic effect while monitoring for tolerability and efficacy.
The daily liraglutide injection pen is administered once daily and is suitable for adults requiring a more frequent dosing schedule.
Dosing is initiated at a lower strength and gradually increased based on patient response. This established GLP-1 agonist is chosen for patients who may not tolerate weekly injections or who respond best to a daily regimen.
Prescription weight loss injection pens—including those containing semaglutide, tirzepatide, or liraglutide—are not suitable for everyone. These treatments are intended for adults who meet specific clinical criteria and should only be started after a comprehensive medical assessment by a qualified doctor in Singapore.
Weight loss injection pens with semaglutide, tirzepatide, or liraglutide may be considered for adults who:
These criteria apply to all GLP-1 and dual agonist treatments, including once-weekly semaglutide or tirzepatide injections and daily liraglutide injections.
Before prescribing semaglutide, tirzepatide, or liraglutide injection pens, your doctor will conduct a detailed medical evaluation. This includes a review of your health history, current medications, and any relevant risk factors. These prescription treatments are generally not recommended for:
Your doctor will also consider any other health conditions that may affect the safety of using a GLP-1 or dual agonist medication.
Patients prescribed semaglutide, tirzepatide, or liraglutide for weight loss will require regular follow-up appointments. Your doctor will monitor your progress, review any potential side effects, and adjust your dosing as needed to ensure continued safety and effectiveness of the treatment.
Understanding the treatment process helps patients prepare for safe and effective weight loss using prescription injection pens, including those containing semaglutide, tirzepatide, or liraglutide.
Your weight management journey begins with a medical consultation at a licensed clinic in Singapore. During this appointment, your doctor will review your medical history, calculate your body mass index (BMI), and discuss your weight loss goals.
Suitability for a GLP-1 injection pen containing semaglutide or liraglutide, or a dual agonist injection pen containing tirzepatide, is determined based on clinical guidelines and your individual needs.
If eligible, your doctor will prescribe the most appropriate injection pen and provide clear instructions on self-administration. For semaglutide and tirzepatide, treatment usually starts at a lower dose with gradual titration over several weeks to reach the maintenance dose.
Liraglutide, as a daily GLP-1 injection, also follows a gradual dose escalation to enhance tolerability. You will receive training on injection technique, the recommended dosing schedule (weekly for semaglutide or tirzepatide, daily for liraglutide), and safe storage of your medication.
Regular follow-up appointments are required to monitor your weight loss progress, check for side effects, and make any necessary adjustments to your dosing. Your doctor will review your response to semaglutide, tirzepatide, or liraglutide, and assess changes in weight and metabolic health.
Ongoing support and medical supervision are key to maximising the benefits and safety of your treatment.
Combining GLP-1 or dual agonist injection therapy with a reduced-calorie diet, increased physical activity, and healthy lifestyle habits further supports long-term weight loss.
Your doctor may provide or recommend additional resources for nutrition and exercise counselling to help you achieve and sustain your goals.
Numerous clinical trials and real-world studies have demonstrated the effectiveness of GLP-1 receptor agonists and dual agonist injections, such as semaglutide, tirzepatide, and liraglutide, for medical weight management in adults with overweight or obesity.
While results can vary from person to person, many patients in Singapore have achieved significant, sustained weight loss with semaglutide, tirzepatide, or liraglutide injections as part of a comprehensive doctor-supervised programme.
Weight reduction is typically gradual, with the greatest changes seen in the first six to twelve months of treatment.
Ongoing follow-up with your doctor is essential to maximise benefits, monitor side effects, and support long-term success. Combining medication with dietary adjustments and increased physical activity is recommended for best outcomes.
Understanding the potential side effects and safety considerations of prescription weight loss injection pens—such as semaglutide, tirzepatide, and liraglutide—is essential for patients considering GLP-1 or dual agonist therapies in Singapore.
Careful medical supervision and regular follow-up help minimise risks and ensure the safe use of these medications.
Most patients experience mild to moderate side effects when starting GLP-1 or dual agonist weight loss injections. The most frequently reported include:
These side effects are usually temporary and tend to improve as the body adjusts to the medication. Starting at a lower dose and gradually increasing the dosage can help minimise these symptoms.
Although uncommon, some patients may experience more serious side effects, including:
GLP-1 and dual agonist weight loss injections are generally not recommended for individuals with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or a history of severe gastrointestinal disease.
It is important to inform your doctor about all your medical conditions before starting treatment.
Patients prescribed semaglutide, tirzepatide, or liraglutide injection pens will have regular follow-up appointments to monitor for side effects, review lab results, and assess overall response to treatment.
Always contact your doctor immediately if you experience severe abdominal pain, symptoms of an allergic reaction, or any new or concerning side effects during treatment.
Prompt reporting and medical evaluation help ensure that potential complications are identified early and managed appropriately.
Starting prescription weight loss injection therapy, such as GLP-1 or dual agonist injections (semaglutide, tirzepatide, or liraglutide), requires careful medical supervision to ensure safety and optimal results. Here’s what to expect when beginning your treatment journey in Singapore:
Your first step is to schedule an appointment with a doctor experienced in weight management. During the consultation, your medical history, body mass index (BMI), and previous weight loss attempts will be reviewed to determine eligibility for a prescription weight loss injection pen.
If you meet clinical criteria, your doctor will conduct a thorough evaluation to select the most appropriate medication—such as a once-weekly semaglutide or tirzepatide injection, or a daily liraglutide injection. The prescription will include a starting dose and a titration plan based on your individual needs and safety profile.
You will receive detailed instructions on how to use your injection pen, including safe injection techniques, storage requirements, and a dosing schedule. The clinic team will demonstrate the process and answer any questions to ensure you are comfortable and confident in self-administration.
After starting treatment, you will have regular follow-up visits to monitor progress, adjust dosing if needed, and address any side effects or concerns. Ongoing medical supervision helps maximise weight loss results while maintaining safety.
To begin your weight loss journey with a prescription injection pen, book a consultation with our clinic today. Our doctor will provide a personalised assessment and guide you through every step of the process.
Understanding the differences between available GLP-1 and dual agonist weight loss injection pens helps patients and clinicians select the most suitable treatment.
The main injectable medications prescribed in Singapore for medical weight management are semaglutide, tirzepatide, and liraglutide.
Individual results vary, and maximum benefit is usually achieved with ongoing medical supervision and healthy lifestyle changes.
| Feature | Semaglutide | Tirzepatide | Liraglutide |
| Class | GLP-1 receptor agonist | Dual GLP-1/GIP agonist | GLP-1 receptor agonist |
| Dosing Frequency | Once weekly | Once weekly | Once daily |
| Available Dose Range | 0.25mg to 2.4mg/week | 2.5mg to 15mg/week | 0.6mg to 3mg/day |
| Average Weight Loss* | 10–15% (STEP trials) | Up to 20% (SURMOUNT trials) | 5–8% (SCALE trials) |
| Most Common Side Effects | Nausea, GI upset | Nausea, GI upset | Nausea, GI upset |
| Indication | Obesity, diabetes | Obesity | Obesity, diabetes |
* Average weight loss reflects clinical trial results with lifestyle intervention. Individual results may vary.
The choice between semaglutide, tirzepatide, and liraglutide depends on individual medical history, body mass index (BMI), treatment goals, preferences, and potential for side effects.
A comprehensive assessment by your doctor is essential to determine the most appropriate option for safe and effective weight management.
Selecting a reputable and experienced clinic is essential when starting prescription weight loss injection therapy with GLP-1 or dual agonist medications such as semaglutide, tirzepatide, or liraglutide.
Proper medical supervision helps ensure your safety, treatment effectiveness, and ongoing support throughout your weight loss journey.
To begin treatment with prescription weight loss injection pens in Singapore, schedule a consultation with a licensed medical aesthetic clinic.
During your visit, the doctor will perform a medical evaluation, discuss your goals, and recommend the most suitable option—such as semaglutide, tirzepatide, or liraglutide injections.
For more information or to book an appointment, please contact our clinic.
What Is the Difference Between the Weekly Semaglutide Injection Pen and the Daily GLP-1 Injection Pen?
The weekly semaglutide injection pen—known internationally under names such as Ozempic and Wegovy—requires a single injection each week, while the daily GLP-1 injection pen (commonly recognised as Saxenda) is administered once per day. Your doctor will recommend the most suitable option based on your medical profile and lifestyle needs.
How Much Weight Can I Expect to Lose With High-Dose Weekly Weight Loss Injection Pens or Dual Agonist Injections?
High-dose weekly injection pens containing semaglutide (such as Wegovy) have demonstrated average weight loss of 10–15% of initial body weight in clinical trials. Dual agonist injection pens containing tirzepatide (like Mounjaro) have shown even greater results, with some patients achieving up to 20% weight loss in studies. Individual results depend on various factors, including adherence and lifestyle changes.
Is the Dual Agonist Weekly Injection Pen Available in Singapore?
The dual agonist weekly injection pen—containing tirzepatide and recognised overseas as Mounjaro—is becoming more accessible in Singapore through licensed medical clinics. Please contact our clinic for the latest updates on availability and prescription requirements.
What Is the Difference Between the Standard Weekly Semaglutide Injection and the High-Dose Version?
Both the standard and high-dose weekly semaglutide injection pens contain the same active ingredient but differ in maximum dose. The standard pen (often called Ozempic) is primarily for diabetes management and can support weight loss, while the high-dose version (Wegovy) is specifically indicated for obesity and supports doses up to 2.4mg weekly.
Who Is Eligible for Weekly Semaglutide, Dual Agonist, or Daily GLP-1 Injection Pens?
Eligibility is typically based on your BMI, presence of weight-related medical conditions, and previous response to lifestyle modifications. Weekly semaglutide (Ozempic, Wegovy), dual agonist (Mounjaro), and daily GLP-1 (Saxenda) injection pens are usually prescribed for adults with a BMI of 27 kg/m² and above, or 30 kg/m² and above without comorbidities.
What Are the Common Side Effects of Weekly or Daily GLP-1 and Dual Agonist Injections?
All GLP-1 and dual agonist injections, including those sold as Ozempic, Wegovy, Mounjaro, and Saxenda, may cause gastrointestinal side effects such as nausea, vomiting, diarrhoea, and reduced appetite. Most symptoms are mild and improve over time, especially with gradual dose escalation under medical supervision.
How Are Weekly and Daily Injection Pens Administered?
Weekly injection pens (Ozempic, Wegovy and Mounjaro) are administered once a week via subcutaneous injection, while daily pens (Saxenda) are used every day. Your doctor will provide full training on injection technique and safe medication handling.
Can I Switch From a Daily to a Weekly Injection Pen, or Between Different Weekly Injections?
Switching between GLP-1 and dual agonist injection pens may be recommended if you do not achieve satisfactory results or experience side effects. Transitioning between options such as Saxenda, Ozempic, Wegovy, or Mounjaro should always be managed by your doctor, who will develop a personalised protocol for safe switching.
What Is the Price Range for Weekly and Daily Weight Loss Injection Pens in Singapore?
The cost of weekly and daily prescription weight loss injection pens varies by medication, dose, and clinic. Generally, newer options such as Wegovy and Mounjaro are priced higher than standard semaglutide (Ozempic) or daily liraglutide (Saxenda). Contact our clinic for current pricing and available packages.
How Do I Start Treatment With a Weekly Semaglutide, Dual Agonist, or Daily GLP-1 Injection Pen in Singapore?
To begin treatment with any of these prescription injection pens, book a consultation with a qualified doctor in Singapore. After a detailed assessment, your doctor will determine whether you are suitable for options such as Ozempic, Wegovy, Mounjaro, or Saxenda, and provide you with full guidance and ongoing support.
Can Weekly or Daily Weight Loss Injection Pens Be Combined With Other Weight Management Treatments?
Prescription weight loss injection pens such as Ozempic, Wegovy, Mounjaro, or Saxenda are typically used as stand-alone medical therapies. Combining these with other prescription weight loss medications is not recommended unless advised by your doctor. They may, however, be used alongside lifestyle interventions, such as a reduced-calorie diet, regular exercise, and behavioural support.
How Long Does It Take to See Results From Weekly or Daily GLP-1 or Dual Agonist Injections?
Patients using medications like Ozempic, Wegovy, Mounjaro, or Saxenda may begin to notice weight loss within the first few weeks of treatment. Most significant results are observed over three to six months, with ongoing improvement for as long as treatment continues and lifestyle changes are maintained.
Are Prescription Weight Loss Injection Pens Safe for Long-Term Use?
GLP-1 and dual agonist injection pens (such as Ozempic, Wegovy, Mounjaro, and Saxenda) have been studied for safety in long-term clinical trials. While they are considered safe for ongoing use under medical supervision, your doctor will regularly monitor your progress and adjust treatment as needed to minimise risks and manage any side effects.
What Should I Do If I Miss a Dose of My Weekly or Daily Injection Pen?
If you miss a dose of your weekly injection pen (such as Ozempic, Wegovy, or Mounjaro), take the missed dose as soon as you remember if it is within a few days, then resume your regular schedule. For daily pens (like Saxenda), take the missed dose as soon as possible but skip it if it’s almost time for your next scheduled dose. Always follow your doctor’s instructions for missed doses.
Can These Weight Loss Injection Pens Be Used for Diabetes and Weight Management?
Certain injection pens, such as Ozempic and Saxenda (both containing semaglutide and liraglutide, respectively), were initially developed for type 2 diabetes management and are now also approved for weight loss. Wegovy and Mounjaro are specifically indicated for weight management but may also have benefits for blood sugar control in some patients. Your doctor will prescribe the most appropriate option based on your health profile.
Are There Any Dietary Restrictions While Using Weekly or Daily Weight Loss Injection Pens?
There are no strict dietary restrictions while using GLP-1 or dual agonist injection pens such as Ozempic, Wegovy, Mounjaro, or Saxenda. However, for optimal results, a reduced-calorie, balanced diet and regular physical activity are strongly recommended. Your doctor or clinic may provide additional dietary guidance to maximise treatment effectiveness.
Is Prior Authorisation or Special Approval Needed to Start Weekly or Daily Injection Pen Therapy in Singapore?
All prescription weight loss injection pens, including options like Ozempic, Wegovy, Mounjaro, and Saxenda, require a valid doctor’s prescription in Singapore. No special authorisation is needed beyond your doctor’s assessment, but not all clinics may offer every option. Booking a medical consultation is the first step.
What Should I Do If I Experience Side Effects From My Weekly or Daily Injection Pen?
If you experience mild side effects (such as nausea or mild stomach upset) from your weight loss injection pen (Ozempic, Wegovy, Mounjaro, or Saxenda), notify your doctor at your next follow-up. For severe symptoms such as persistent vomiting, dehydration, or severe abdominal pain, seek medical attention promptly. Dose adjustments or alternative medications may be recommended.
Can I Use a Weekly or Daily Weight Loss Injection Pen if I Am Planning Pregnancy?
Prescription weight loss injection pens (including Ozempic, Wegovy, Mounjaro, and Saxenda) are not recommended during pregnancy or if you are planning to conceive. Inform your doctor if you are pregnant, breastfeeding, or planning pregnancy so that appropriate alternatives can be discussed.
Are Weight Loss Injection Pens Suitable for Younger Adults or Teenagers?
Most weekly and daily weight loss injection pens, such as Ozempic, Wegovy, Mounjaro, and Saxenda, are approved for adults aged 18 and above. Use in adolescents or children is not routinely recommended unless specifically approved and supervised by a specialist.
Tirzepatide weekly weight loss injection is now available in Singapore! Enquire Now! to WhatsApp us and speak with our team directly.
Tirzepatide is a once-weekly weight loss injection developed by Eli Lilly, now available for medical weight management in Singapore. Classified as a dual agonist, tirzepatide acts on both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This mechanism is distinct from traditional single-pathway treatments.
The medication is administered by subcutaneous injection, with a dosing protocol that typically ranges from 2.5mg to 15mg once weekly. Clinical trials have shown that tirzepatide can support significant weight reduction when prescribed as part of a doctor-supervised program.
This page provides a detailed overview of tirzepatide dual agonist weekly weight loss injections in Singapore, including its mechanism of action, clinical evidence, safety considerations, dosing, and key information for individuals considering this treatment.
Tirzepatide dual agonist injection is a prescription medication used for medical weight management in Singapore.
Unlike earlier medications that act only on GLP-1 receptors, tirzepatide targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors.
This dual mechanism provides a different approach to appetite regulation and metabolic control compared to single-pathway treatments.
Tirzepatide is a once-weekly injectable medication for adults with obesity or overweight. Its dual agonist profile means it stimulates both GIP and GLP-1 receptors, which are hormones involved in appetite regulation and glucose metabolism.
Tirzepatide was developed by Eli Lilly to offer an additional option for chronic weight management.
GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) are incretin hormones naturally produced in the gut in response to food intake. These hormones play essential roles in regulating blood sugar, appetite, and energy balance.
When food is consumed, both GIP and GLP-1 are released and signal to the pancreas to increase insulin secretion while suppressing glucagon release. This process helps to maintain stable blood glucose levels, particularly after meals.
Beyond their effects on insulin and glucagon, these hormones also communicate with the brain to promote satiety and reduce overall food intake.
GLP-1 receptor agonists, which have been used for several years in medical weight management, act specifically on GLP-1 receptors. They increase feelings of fullness, delay gastric emptying, and can lead to reduced calorie consumption.
However, tirzepatide’s dual agonist design means it also activates GIP receptors in addition to GLP-1 receptors.
The inclusion of GIP receptor activation is believed to provide additional benefits for weight management. GIP agonism can further enhance insulin release, improve glucose tolerance, and may have independent effects on appetite regulation.
When combined with GLP-1 receptor activation, the result is a more comprehensive effect on appetite control, glucose metabolism, and energy expenditure.
Clinical studies have shown that dual GIP and GLP-1 receptor agonist therapy can lead to greater reductions in body weight and improvements in metabolic health compared to single agonist treatments. This mechanism is the foundation for the observed clinical outcomes with tirzepatide injections.
Single agonist weight loss injections, such as those containing GLP-1 receptor agonists like semaglutide and liraglutide, act only on the GLP-1 pathway. These medications help with weight loss by increasing feelings of fullness, reducing appetite, and slowing gastric emptying.
Semaglutide and liraglutide have been widely prescribed in Singapore for medical weight management and are well established in clinical practice.
Tirzepatide, by contrast, is classified as a dual agonist injection because it activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. By engaging two metabolic pathways rather than one, tirzepatide delivers a broader and more comprehensive effect on appetite regulation, glucose control, and energy balance.
Clinical studies have demonstrated that dual agonist therapy with tirzepatide can result in greater weight reduction and improved metabolic outcomes compared to single agonist GLP-1 treatments such as semaglutide and liraglutide.
The dual mechanism of action is a key distinguishing feature, making tirzepatide a distinct option among injectable weight loss medications available in Singapore.
Tirzepatide’s role in medical weight management is supported by extensive clinical research. Multiple large-scale trials have examined its effectiveness, safety profile, and comparative outcomes against other weight loss injections such as semaglutide.
Tirzepatide’s weight loss efficacy has been studied in a series of global clinical trials known as the SURMOUNT program. SURMOUNT-1 and SURMOUNT-2 are the most notable, involving adults with obesity or overweight, with or without type 2 diabetes.
In SURMOUNT-1, participants treated with tirzepatide over 72 weeks experienced average weight reductions of up to 20.9% of their baseline body weight, depending on the dose used.
The SURMOUNT-2 study, which included individuals with type 2 diabetes, showed an average weight loss of up to 15.7%. These results are considered among the most substantial weight reductions reported for injectable weight loss medications to date.
References:
SURMOUNT-1 (Tirzepatide in Obesity Without Diabetes)
SURMOUNT-2 (Tirzepatide in Obesity With Type 2 Diabetes)
Most patients using tirzepatide injections for weight loss begin to see measurable results within the first 4 to 8 weeks of treatment, with maximum weight reduction typically observed by week 72 in clinical studies.
The amount of weight lost can vary based on the prescribed dose and individual response, but the majority of participants in studies achieved weight reductions exceeding 15% of their starting weight.
Comparative studies have shown that tirzepatide produces greater average weight loss than single agonist GLP-1 injections, such as semaglutide and liraglutide. For example, in head-to-head analyses, tirzepatide has been associated with higher percentages of total body weight lost compared to semaglutide.
The SURMOUNT-5 head-to-head clinical trial demonstrated that tirzepatide 15 mg resulted in an average body weight loss of 20.2% at 72 weeks, compared to 13.7% with semaglutide over the same period.
You can read the published results here
These findings support tirzepatide’s use as an option for adults seeking doctor-supervised injectable weight loss treatment in Singapore.
Tirzepatide dual agonist injections are intended for adults seeking medical weight management under the supervision of a qualified healthcare provider in Singapore. Patient suitability is determined by several factors, including body mass index (BMI), medical history, and individual treatment goals.
Tirzepatide is generally prescribed for adults with a BMI of 30 kg/m² or higher (classified as obesity), or 27 kg/m² or higher with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or dyslipidemia.
Assessment of overall health status, history of cardiovascular disease, and risk factors is also important before starting treatment.
A thorough consultation is necessary to evaluate eligibility for tirzepatide injections. This includes a review of current medical conditions, previous weight loss attempts, current medications, and relevant blood tests.
Doctors may also consider the patient’s motivation, treatment expectations, and ability to comply with regular follow-up appointments.
Tirzepatide is not suitable for individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or those with a known hypersensitivity to any of its components.
Caution is also advised in patients with a history of pancreatitis, severe gastrointestinal disease, or certain psychiatric disorders. Tirzepatide is not recommended during pregnancy or breastfeeding.
Tirzepatide dual agonist injections are provided as part of a structured medical weight management program in Singapore. The treatment process involves several key steps to ensure patient safety, effective weight reduction, and ongoing clinical support.
Before starting tirzepatide dual agonist weight loss injections in Singapore, patients undergo a comprehensive medical consultation. This includes assessment of weight, BMI, medical history, and baseline laboratory investigations. The doctor will review previous weight management efforts and discuss expected benefits and possible risks associated with tirzepatide therapy.
Tirzepatide is administered as a subcutaneous injection once weekly. Treatment starts at 2.5 mg per week and is gradually increased every four weeks: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, up to a maximum of 15 mg per week.
Dose titration is based on individual tolerability and clinical response, optimizing both safety and weight loss outcomes. Adjustments are made according to each patient’s needs.
Regular follow-up appointments are scheduled at the clinic in Singapore to monitor progress, assess dosing, and manage any potential side effects. Patients are encouraged to attend ongoing reviews to track weight, metabolic health, and overall response to tirzepatide injections.
For patients switching to tirzepatide from another weight loss injection, such as semaglutide or liraglutide, a tailored transition plan is developed by the doctor. This may involve a medication washout period or careful timing of injections to reduce the risk of side effects and support treatment continuity.
Tirzepatide dual agonist injections are generally well tolerated, but like all medications, they may cause side effects in some individuals.
Understanding the safety profile of tirzepatide is important for anyone considering this weight loss injection as part of a medical weight management program in Singapore.
The most frequently reported side effects of tirzepatide injections include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, constipation, and abdominal discomfort.
These side effects are most common during the initial dose escalation phase and often become less pronounced as the body adjusts to the medication.
Other possible side effects include decreased appetite, fatigue, and mild injection site reactions such as redness or swelling.
Although uncommon, tirzepatide has been associated with rare but serious adverse effects. These include pancreatitis (inflammation of the pancreas), severe gastrointestinal disease, and possible allergic reactions.
There is also a theoretical risk of medullary thyroid carcinoma, as observed with other medications in the GLP-1 receptor agonist class. Individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 are generally advised not to use tirzepatide.
Caution is advised when considering tirzepatide for patients with certain health conditions. Tirzepatide is not recommended for use during pregnancy or breastfeeding, and its safety has not been established in children or adolescents.
Individuals with a history of pancreatitis, severe gastrointestinal disorders, or certain psychiatric illnesses should discuss potential risks and benefits with their doctor before starting tirzepatide therapy.
Tirzepatide dual agonist injections for weight loss are available in Singapore by prescription and should only be started under the supervision of a licensed medical professional.
At our clinic, patients receive a comprehensive assessment and ongoing clinical support from Dr Edwin Lim and his medical team throughout their tirzepatide weight management journey.
Tirzepatide is not available over the counter in Singapore. A doctor’s prescription is required, and therapy must be tailored to each patient’s health status.
Your doctor will conduct a thorough evaluation—including medical history, physical examination, and relevant laboratory tests—before recommending tirzepatide as part of a structured medical weight management program.
After the initial assessment, tirzepatide injections may be self-administered at home following proper instruction, or performed at the clinic under medical supervision if preferred.
Regular follow-up appointments are essential to monitor progress, review dosing, and address any side effects. Ongoing supervision ensures that tirzepatide treatment remains both safe and effective.
Doctor-led supervision is essential for the safe use of tirzepatide dual agonist injections in Singapore. Regular monitoring allows for prompt management of any adverse effects, timely dose adjustments, and ongoing lifestyle guidance. Patients are encouraged to attend all scheduled reviews and communicate any concerns throughout their treatment.
Sustaining weight loss after completing a tirzepatide dual agonist injection program is a key consideration for individuals in Singapore. Understanding long-term outcomes, maintenance strategies, and insights from clinical studies can help patients plan for lasting weight control.
Clinical data from the SURMOUNT‑4 study indicate that some weight regain typically occurs after discontinuing tirzepatide.
However, most participants maintained a significant reduction compared to their original baseline even after stopping treatment.
To support long-term weight maintenance, patients are encouraged to continue healthy dietary habits, regular exercise, and behavioral techniques introduced during therapy.
Ongoing support from healthcare providers can help reinforce these practices and address any weight regain early. Periodic check-ins with your doctor can guide appropriate management adjustments.
Continued medical monitoring after stopping tirzepatide injections is advised. Regular follow-up appointments in Singapore can help evaluate metabolic health, reinforce lifestyle strategies, and discuss further treatment options if needed.
Patients experiencing weight regain or health changes may consult their doctor about resuming tirzepatide or considering alternative interventions.
Finding the right clinic for dual agonist (GIP and GLP-1) weekly weight loss injections in Singapore is essential for safe, effective, and personalised medical care. When selecting a provider, patients should consider several key factors to ensure optimal results.
Look for clinics where weight management treatments are led by experienced doctors who are familiar with dual agonist injections, such as tirzepatide. Doctor supervision ensures that your eligibility is thoroughly assessed, dosing is appropriately titrated, and any side effects are promptly managed.
A reputable clinic should have experience administering the latest injectable weight loss medications, including dual agonist (GIP and GLP-1) therapies. Ask about the clinic’s approach to patient education, safety protocols, and ongoing follow-up to support long-term success.
Effective weight loss requires more than just medication. The best clinics offer comprehensive support, including tailored lifestyle advice, nutrition counselling, and regular monitoring. Ongoing reviews allow your doctor to adjust treatment as needed and address any challenges during your weight management journey.
If you are interested in dual agonist weight loss injections or want to discuss your options with a qualified medical team, schedule a consultation with our clinic.
Contact us to learn more about our doctor-led, evidence-based weight management programmes in Singapore.
What Is the Dual GIP and GLP-1 Weekly Injection Used for Weight Loss in Singapore?
The dual GIP and GLP-1 weekly injection used for weight loss in Singapore is known commercially as Mounjaro (tirzepatide). Mounjaro is a once-weekly injectable medication developed by Eli Lilly and approved for medical weight management. It acts on both GIP and GLP-1 receptors to reduce appetite, improve glucose control, and promote significant weight loss.
How Does the Latest Dual Agonist Injection for Weight Loss Compare to Other Treatments?
Mounjaro (tirzepatide) differs from earlier weight loss injections, such as Ozempic (semaglutide), Wegovy, and Saxenda (liraglutide), by targeting two metabolic pathways: GIP and GLP-1 receptors. This dual mechanism has been shown in clinical studies to produce greater average weight loss than single agonist treatments. In the SURMOUNT-5 trial, Mounjaro 15 mg resulted in 20.2% average body weight loss at 72 weeks, compared to 13.7% with semaglutide.
What Dosing Protocol Is Used for the Dual Agonist Weekly Weight Loss Injection?
Mounjaro (tirzepatide) is administered as a subcutaneous injection once weekly. The dosing protocol starts at 2.5 mg per week and increases every four weeks to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and up to a maximum of 15 mg per week. Dose titration is adjusted based on tolerability and clinical response under doctor supervision.
How Soon Can I Expect to See Results With the Dual Agonist Injection?
With Mounjaro, most patients begin to see appetite changes and initial weight loss within the first 4–8 weeks. Clinical studies such as SURMOUNT-1 have shown progressive weight reduction over 72 weeks, with average losses exceeding 15–20% of baseline body weight, depending on the dose.
What Happens If I Stop the Dual Agonist Weekly Injection?
After discontinuing Mounjaro injections, some degree of weight regain is expected, as observed in the SURMOUNT-4 study. However, many patients retain a portion of their weight loss compared to their original baseline. Long-term lifestyle changes and regular medical follow-up are important for weight maintenance after stopping Mounjaro.
Can I Switch to the Dual Agonist Injection From Another Weight Loss Medication?
Yes, it is possible to switch to Mounjaro from other weight loss injections such as Ozempic, Wegovy, or Saxenda. Your doctor will determine the appropriate transition plan to minimize side effects and ensure optimal treatment continuity.
Is the Dual Agonist Weekly Injection Approved in Singapore?
Mounjaro (tirzepatide) is approved in Singapore for medical weight management and is available by prescription only. Treatment should be initiated and supervised by a qualified doctor with experience in medical weight loss programs.
Who Is Suitable for the Dual GIP and GLP-1 Weekly Weight Loss Injection?
Mounjaro is suitable for adults with a BMI of 30 kg/m² or higher, or 27 kg/m² or higher with weight-related health conditions such as type 2 diabetes or hypertension. Suitability is determined by a doctor based on individual medical history, risk factors, and weight loss goals.
Are There Any Side Effects With the Dual Agonist Weight Loss Injection?
Mounjaro can cause side effects, most commonly gastrointestinal symptoms like nausea, vomiting, diarrhoea, or constipation. These effects usually occur during dose escalation and tend to decrease over time. Less common but serious risks include pancreatitis and, rarely, thyroid-related conditions. Patients should report any severe or persistent symptoms to their doctor promptly.
How Much Does the Dual Agonist Weekly Weight Loss Injection Cost in Singapore?
The cost of Mounjaro injections in Singapore can vary depending on the prescribed dose and clinic. On average, the monthly price ranges from approximately $600 to $1,200 before GST. For the latest pricing and package options, please contact us.
Can the Dual Agonist Injection Be Combined With Other Weight Loss Methods?
Mounjaro is most effective when combined with healthy dietary habits, regular exercise, and ongoing medical supervision. Some patients may use Mounjaro in conjunction with other non-injectable weight loss strategies. Always consult your doctor before combining medications or therapies.
How Do I Start the Dual Agonist Weekly Injection in Singapore?
To begin treatment with Mounjaro in Singapore, schedule a consultation with a doctor experienced in medical weight management. After an initial assessment and confirmation of suitability, your doctor will provide detailed instructions for dosing, self-injection, and follow-up care.
Can the Dual Agonist Weekly Injection Be Used for Weight Loss Without Diabetes?
Yes, Mounjaro (tirzepatide) is approved for weight management in adults regardless of diabetes status. Clinical studies, such as SURMOUNT-1, specifically evaluated its use in individuals with obesity or overweight who do not have type 2 diabetes, demonstrating substantial weight loss results.
What Should I Do If I Miss a Dose of the Dual Agonist Weight Loss Injection?
If you miss a scheduled Mounjaro (tirzepatide) injection, administer the missed dose as soon as possible within four days. If more than four days have passed, skip the missed dose and continue with your next scheduled injection. Do not take two doses within three days of each other. If unsure, consult your doctor for guidance.
Is Ongoing Blood Test Monitoring Required With the Dual Agonist Injection?
During Mounjaro treatment, your doctor may recommend periodic blood tests to monitor metabolic parameters, such as blood glucose, cholesterol, and liver function. Ongoing monitoring helps ensure the safe and effective use of tirzepatide injections as part of a comprehensive weight management plan in Singapore.
How Long Can I Stay on the Dual Agonist Weekly Injection for Weight Loss?
The duration of Mounjaro (tirzepatide) treatment is individualized. Some patients may continue therapy long-term to maintain weight loss and metabolic benefits, while others may stop after reaching their target weight. Your doctor will discuss an appropriate treatment plan and adjust the duration based on your progress and health goals.
Are There Any Food or Drug Interactions With the Dual Agonist Injection?
Mounjaro (tirzepatide) has no significant food restrictions. However, your doctor should review all your current medications to minimize potential drug interactions, especially with other diabetes or weight loss treatments. Inform your doctor about all supplements and medicines you are taking.
Is There a Waiting List or Limited Supply for the Dual Agonist Injection in Singapore?
As demand for Mounjaro (tirzepatide) is high, there may be occasional waiting lists or supply fluctuations at some clinics in Singapore. For the latest updates on availability or to reserve your treatment slot, please contact us.
What Lifestyle Changes Should I Make While on the Dual Agonist Weekly Injection?
For optimal results with Mounjaro, patients are advised to adopt healthy dietary habits, increase physical activity, and address behavioral factors related to weight management. Your doctor or clinic team can provide specific lifestyle guidance tailored to your needs during treatment.
Can Mounjaro Be Used Together With Other Weight Loss Injections?
Combining Mounjaro (tirzepatide) with other injectable weight loss medications such as Ozempic, Wegovy, or Saxenda is generally not recommended. Dual therapy may increase the risk of side effects and has not been shown to improve efficacy. Always consult your doctor before making any changes to your medication regimen.
Are There Any Contraindications for the Dual Agonist Injection?
Mounjaro should not be used in patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or known hypersensitivity to tirzepatide or its components. Your doctor will evaluate your full medical history before prescribing this treatment.
Laser mole removal in Singapore is a minimally invasive procedure that targets unwanted moles for aesthetic or medical purposes. Moles, also known as nevi, are clusters of pigmented skin cells that can vary in size, color, and texture. While most moles are harmless, some individuals choose to remove them due to cosmetic concerns, irritation, or medical recommendations.
This procedure uses advanced laser technology to remove moles precisely, ensuring minimal damage to surrounding skin. With little discomfort and no stitches required, laser mole removal is a popular and effective solution for mole removal in Singapore.
Laser mole removal is a versatile procedure suitable for a wide range of individuals. It is particularly ideal for those who:
Laser mole removal is not recommended for individuals with atypical or suspicious moles that may require further medical evaluation or biopsy. During a consultation, your doctor will assess the mole to ensure that laser treatment is the most suitable option.
Laser mole removal in Singapore is a safe and effective method for eliminating unwanted moles using advanced technology like the Lutronic eCO2 laser. The process involves precise targeting and minimal impact on surrounding skin. Here’s how it works:
This advanced laser procedure offers precise results with minimal discomfort and downtime, making it a popular choice for mole removal in Singapore.
Laser mole removal ensures accurate targeting of the mole without damaging the surrounding skin. The Lutronic eCO2 laser provides precise treatment, reducing risks and improving outcomes.
Whether removing a mole for cosmetic enhancement or addressing a medical issue, laser mole removal offers a versatile solution tailored to individual needs.
Unlike traditional surgical methods, laser mole removal minimizes scarring and promotes faster healing, making it ideal for moles in visible areas such as the face, neck, or hands.
Each mole typically takes 5–10 minutes to treat, and multiple moles can be removed within 30 minutes. This makes it a practical choice for those with busy schedules.
The laser technology is effective for all skin tones and mole types, ensuring safe and consistent results for everyone.
Laser mole removal is a straightforward process. Here’s what you can expect during the procedure:
With minimal downtime, laser mole removal allows most patients to resume their normal activities shortly after the procedure.
Laser mole removal is a safe and effective procedure, but like any medical treatment, it may involve some mild side effects and rare risks. Here’s what you need to know:
Most side effects are mild and temporary, including:
While uncommon, some risks associated with laser mole removal include:
To ensure safe healing and reduce the likelihood of side effects:
Is Laser Mole Removal Painful?
Laser mole removal is a minimally invasive procedure, and most patients experience little to no discomfort. The application of numbing cream or local anesthesia ensures the process is virtually pain-free.
How Long Does Laser Mole Removal Take?
Each mole takes approximately 5–10 minutes to remove, depending on its size and location. For multiple moles, the entire session is usually completed within 30 minutes, making it a quick and convenient treatment option.
Will the Mole Grow Back After Laser Removal?
Moles removed using laser technology are unlikely to regrow in the same spot as the laser effectively destroys the mole tissue. However, the risk of recurrence exists due to factors such as DNA mutations within the skin cells. Additionally, new moles may develop over time as a result of genetics, hormonal changes, or prolonged sun exposure. While laser removal addresses the existing mole, underlying biological factors may lead to the formation of new moles in the future.
Is Laser Mole Removal Suitable for All Moles?
Laser mole removal is ideal for flat or slightly raised moles. Larger, deeply rooted, or atypical moles may require alternative methods such as surgical excision. During your consultation, the doctor will recommend the most suitable option for your mole type.
Are There Any Aftercare Requirements for Laser Mole Removal?
Proper aftercare is crucial for optimal healing and results:
Do I Need to Avoid Certain Foods Like Seafood or Dark Sauce?
No, there are no dietary restrictions after laser mole removal. You can continue your regular diet, including seafood and dark sauces, without affecting the healing process.
How Much Does Laser Mole Removal Cost in Singapore?
The cost of laser mole removal in Singapore varies based on the size, type, and number of moles being treated. On average, prices range from SGD 150 to SGD 500 per mole. Larger or more complex moles may incur higher costs.
Why Choose Laser Mole Removal in Singapore?
Laser mole removal is a safe, quick, and precise solution for addressing unwanted moles. Whether for cosmetic enhancement or medical concerns, this procedure offers minimal downtime, low risks, and long-lasting results.
Laser wart removal in Singapore is a safe and non-invasive procedure designed to effectively eliminate unwanted warts. Warts are small, rough skin growths caused by the human papillomavirus (HPV) and can appear on various parts of the body, including the hands, feet, and face. While warts are generally harmless, they may cause discomfort, spread to other areas, or impact appearance, leading many individuals to seek professional treatment.
This advanced laser wart removal procedure uses targeted laser technology to destroy the wart tissue without affecting the surrounding healthy skin. The laser’s heat energy penetrates the wart, breaking down its structure and preventing recurrence.
With minimal discomfort, no stitches required, and little downtime, laser wart removal treatment in Singapore is a preferred choice for those seeking precise and effective wart removal. This procedure is suitable for warts of various sizes and locations, offering patients a convenient and reliable solution.
Laser wart removal in Singapore is an effective and versatile treatment suitable for individuals with various needs. It is particularly ideal for those who:
Laser wart removal in Singapore is a safe, effective, and precise method for eliminating unwanted warts. This procedure uses advanced laser technology, such as the Lutronic eCO2 laser, to target and destroy the wart tissue with minimal impact on the surrounding healthy skin.
Here’s how the process works:
This non-invasive wart removal procedure is quick, typically taking just 5 to 15 minutes per wart, and requires little to no downtime. By utilizing advanced laser technology, laser wart removal in Singapore offers a safe and effective solution for warts of various sizes and locations.
Laser wart removal offers numerous advantages, making it a preferred choice for individuals seeking a safe and effective solution for warts. Below are the key benefits:
The laser precisely targets the wart tissue, ensuring that surrounding healthy skin is unaffected. This reduces the risk of complications and makes the procedure suitable for sensitive or highly visible areas like the face or hands.
Laser wart removal is a non-invasive procedure that does not involve cutting or stitching. Most patients experience only mild discomfort, thanks to the precision of the laser and the use of numbing cream during the treatment.
Unlike traditional methods such as freezing or surgical excision, laser treatment minimizes scarring and promotes quicker healing. The scab that forms after treatment naturally falls off within 1–2 weeks, revealing smooth, clear skin.
For warts that have not responded to over-the-counter remedies or other treatments like cryotherapy, laser removal provides a reliable and efficient alternative.
Each wart typically takes just 5 to 15 minutes to treat, and multiple warts can be removed in a single session. This makes it an ideal solution for busy individuals who want a fast, effective treatment with minimal downtime.
Advanced laser technology ensures safe and effective treatment for all skin tones and for warts located on various parts of the body, including the feet, hands, face, and even sensitive areas such as genitalia.
The laser wart removal procedure in Singapore is straightforward and minimally invasive. Here’s what you can expect during the process:
With minimal downtime, most patients can resume their daily activities immediately after the procedure.
Laser wart removal is a safe and effective procedure, but like any medical treatment, it may involve some mild side effects and rare risks. Here’s what you need to know:
Most side effects are temporary and mild, including:
While uncommon, some individuals may experience:
To ensure safe healing and reduce the likelihood of side effects:
Is Laser Wart Removal Painful?
Laser wart removal is a minimally invasive procedure, and most patients experience little to no discomfort. The application of numbing cream or local anesthesia ensures a pain-free treatment.
How Long Does the Procedure Take?
Each wart typically takes 5–15 minutes to remove. For multiple warts, the session may take more than 30 minutes, making laser wart removal a quick and convenient option for busy individuals.
Will the Wart Grow Back After Laser Removal?
Once a wart is removed using laser technology, it is unlikely to regrow in the same spot, as the laser effectively destroys the wart tissue. However, new warts may develop in other areas due to exposure to the human papillomavirus (HPV). Proper hygiene and care can help minimize this risk.
Is Laser Wart Removal Suitable for All Warts?
Laser wart removal is effective for most types of warts, including common warts, plantar warts, and flat warts. However, warts in highly sensitive or complex areas may require additional evaluation. Your doctor will recommend the best treatment based on the wart’s size, location, and type.
Are There Any Aftercare Requirements?
Yes, proper aftercare is essential to ensure optimal healing and results:
How Much Does Laser Wart Removal Cost in Singapore?
The cost of laser wart removal in Singapore varies based on the size, type, and number of warts being treated. On average, prices range from SGD 150 to SGD 500 per wart.
Copyrights 2026 by Edwin Lim Medical Aesthetic Clinic Pte. Ltd.
